Crinetics Pharmaceuticals Announces October 2025 Inducement Grants Under Nasdaq Listing Rule ...

SAN DIEGO, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on October 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 78,975 shares...

Read Full Article →